Immutable Holdings Announces Voting Results for its Annual General and Special Meeting of Shareholders
December 31, 2025 18:02 ET | Source: Immutable Holdings Inc. VANCOUVER, British…
TraceLink Earns Top-Tier ISO, SOC, and CyberVadis Results, Confirming Its Position as the Most Trusted Agentic Orchestration Platform for Life Sciences
Independent audits and a Platinum CyberVadis rating demonstrate the rigor, resilience, and…
OBOOK Holdings Inc. Announces Unaudited Financial Results for the First Half of 2025 Ended June 30, 2025; Core Infrastructure Transition Near Completion; Enterprise Activation and Monetization
ARLINGTON, Va., Dec. 30, 2025 (GLOBE NEWSWIRE) -- OBOOK Holdings Inc. (NASDAQ:…
Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype
The secondary analysis of the PACE trial highlights the value of counting…
Teva to Host Conference Call to Discuss Fourth Quarter 2025 Financial Results at 8 a.m. ET on January 28, 2026
December 12, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL…
FitLine x Paris Basketball: Performance and Results at the Highest Level
LUXEMBOURG and PARIS, Dec. 10, 2025 /PRNewswire/ -- FitLine is proud to…
Mercedes star shines bright as Euro NCAPs final results deliver safer options for every buyer
LEUVEN, BELGIUM – Euro NCAP’s independent assessment of the new CLA shows…
Igyxos Biotherapeutics Announces Positive Results from Phase 1 Trial of IGX12, its First-in-Class Monoclonal Antibody for the Treatment of Male and Female Infertility
December 10, 2025 04:00 ET | Source: Igyxos TOURS, France, Dec. 10,…
Why Transparent, Comparable, and Reliable Security Testing Matters: AV-Comparatives Highlights 2025 Enterprise EPR and EDR Results
INNSBRUCK, Austria, Dec. 9, 2025 /PRNewswire/ -- As cyberattacks continue to challenge…
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a…
